Vanessa D'antongiovanni

Pisa, 56126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms.

A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms.

Journal: International journal of molecular sciences

Published: April 20, 2026

CCR2-dependent monocytes gut-homing contributes to enteric neuroplastic changes in a mouse model of diet-induced obesity.

CCR2-dependent monocytes gut-homing contributes to enteric neuroplastic changes in a mouse model of diet-induced obesity.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 23, 2026

Special Issue "Drugs in Inflammatory Bowel Diseases".

Special Issue "Drugs in Inflammatory Bowel Diseases".

Journal: International journal of molecular sciences

Published: November 24, 2025

Up-regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy.

Up-regulation of the kinase LRRK2, in enteric glia contributes to mucosal barrier impairment in Parkinson's disease via secretory autophagy.

Journal: British journal of pharmacology

Published: October 22, 2025

Enteric Glial Cell Culture to Mimic In Vivo Obesity and Neurodegenerative Disorders.

Enteric Glial Cell Culture to Mimic In Vivo Obesity and Neurodegenerative Disorders.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 01, 2025

Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging.

Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging.

Journal: Molecular nutrition & food research

Published: February 22, 2025

Correction to "Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain".

Correction to "Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain".

Journal: ACS medicinal chemistry letters

Published: December 20, 2024

Correction: Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Correction: Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Journal: Food & function

Published: November 21, 2024

Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Lactiplantibacillus plantarum HEAL9 attenuates cognitive impairment and progression of Alzheimer's disease and related bowel symptoms in SAMP8 mice by modulating microbiota-gut-inflammasome-brain axis.

Journal: Food & function

Published: September 20, 2024

Retraction Note: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.

Retraction Note: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.

Journal: Inflammation

Published: September 14, 2024

Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.

Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.

Journal: Frontiers in pharmacology

Published: July 18, 2024

The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.

The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis.

Journal: Journal of drug targeting

Published: June 12, 2024

Showing 1-12 of 51

Last Updated: 09/26/2026